Related Experiment Video
Updated: Jan 10, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Recurrent Martorell ulcer in a patient with hypertension: a therapeutic success with pentoxifylline
Peter A Sorensen1, Katherine Palmisano1
1Ascension St. Vincent Hospital, Indianapolis, IN, USA.
Background:
Martorell ulcer is a rare skin condition that occurs in individuals with a history of long-standing uncontrolled hypertension. Martorell ulcer is often misdiagnosed on initial evaluation. Treatment primarily consists of tight pharmaceutical control of blood pressure and skin grafting. These treatments have high rates of success and often result in complete healing of the ulcer.
Case Report:
A 68-year-old female with Martorell ulcer on the posterolateral aspect of the left lower limb was unable to undergo either of the aforementioned primary treatments because of a complicated history of cerebral hypoperfusion secondary to multiple strokes that necessitated maintaining her blood pressure at a higher than normal range. After little success with local wound care, the patient was placed on pentoxifylline 400 mg three times a day. Complete healing of the Martorell ulcer was observed, and weaning from pentoxifylline occurred over the course of 28 days. Five months later, the patient presented with recurrence of Martorell ulcer, this time on the contralateral lower limb. Prompt treatment with pentoxifylline was implemented, and the ulcer was completely healed in 29 days.
Conclusion:
This unique case highlights pentoxifylline as a potentially effective alternative treatment for Martorell ulcer in patients who are unable to undergo first-line treatments. The reproducibility of healing on recurrence in this case further supports consideration of this medication in select patients.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
